Werbung
Kursziele der Merck-Aktie
*Das durchschnittliche Kursziel beinhaltet alle Analysen eines Analysten und nicht nur die jeweils aktuellste Analyse, die im Chart dargestellt wird.
Diese Analysten bewerten die Merck-Aktie
| Analyst | Kursziel | Abstand Kursziel | Datum | |
|---|---|---|---|---|
| Barclays Capital | 210,00€ | +18,71% | 22.11.22 | |
| Jefferies & Company Inc. | 210,00€ | +18,71% | 22.11.22 | |
| DZ BANK | - | - | 17.11.22 | |
| Goldman Sachs Group Inc. | 192,00€ | +8,54% | 15.11.22 | |
| Credit Suisse Group | 200,00€ | +13,06% | 14.11.22 | |
| Deutsche Bank AG | 220,00€ | +24,36% | 11.11.22 | |
| JP Morgan Chase & Co. | 250,00€ | +41,32% | 11.11.22 | |
| UBS AG | 184,00€ | +4,01% | 10.11.22 | |
| Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | 204,00€ | +15,32% | 05.08.22 | |
| Bernstein Research | 210,00€ | +18,71% | 14.07.22 | |
| Kepler Cheuvreux | 252,00€ | +42,45% | 13.12.21 |
Kursziele im Branchenvergleich
| Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
|---|---|---|---|---|---|
| 3M Co. | 0 | 0 | 0 | - | - |
| Abbott Laboratories | 0 | 0 | 0 | - | - |
| AstraZeneca PLC | 4 | 3 | 1 | 108,31 £ | - |
| BASF | 8 | 5 | 1 | 60,34 € | +23,52% |
| Bayer | 10 | 1 | 0 | 80,60 € | +46,63% |
| BB Biotech AG | 1 | 0 | 0 | 64,20 € | +5,59% |
| Beiersdorf AG | 9 | 3 | 3 | 104,32 € | -1,49% |
| Biotest AG Vz. | 0 | 0 | 0 | - | - |
| Bristol-Myers Squibb Co. | 0 | 0 | 0 | - | - |
| Clorox Co., The | 0 | 0 | 0 | - | - |
| Colgate-Palmolive Co. | 0 | 0 | 0 | - | - |
| Eli Lilly and Co. | 0 | 0 | 0 | - | - |
| Gilead Sciences Inc. | 0 | 0 | 0 | - | - |
| GSK PLC Registered Shs | 2 | 5 | 1 | 15,42 £ | - |
| H&R GmbH & Co. KGaA | 0 | 0 | 1 | 5,00 € | - |
| H. B. Fuller Co. | 0 | 0 | 0 | - | - |
| Johnson & Johnson | 0 | 0 | 0 | - | - |
| LANXESS AG | 10 | 1 | 0 | 51,00 € | +29,67% |
| L'Oréal S.A. (L'Oreal, L Oreal) | 5 | 5 | 2 | 366,00 € | +1,02% |
| Merck Co. | 0 | 0 | 0 | - | - |
| Merck KGaA | 7 | 3 | 1 | 213,20 € | +20,52% |
| Novartis AG | 2 | 4 | 4 | 84,70 CHF | - |
| Pfizer Inc. | 2 | 4 | 0 | 50,00 $ | -1,75% |
| Procter & Gamble Co. | 0 | 1 | 0 | 165,00 $ | +9,57% |
| Reckitt Benckiser Plc | 9 | 3 | 0 | 73,35 £ | - |
| Roche Holding AG (Inhaberaktie) | 0 | 0 | 0 | - | - |
| Sanofi S.A. | 5 | 4 | 0 | 105,33 € | +23,03% |
| STADA | 0 | 0 | 0 | - | - |
| Takeda Pharmaceutical Co. Ltd. | 0 | 0 | 0 | - | - |
| Unilever plc | 5 | 3 | 3 | 41,68 £ | - |
| WACKER CHEMIE AG | 5 | 3 | 1 | 142,88 € | +14,21% |